MARKET CLOSE: NZ shares rise as vaccine trial boosts global sentiment

MARKET CLOSE: NZ shares rise as vaccine trial boosts global sentiment
Dan Brunskill
New Zealand shares rose for a third day as investors welcomed interim results of a covid-19 vaccine trial which showed a positive immune response to the virus. The S&P/NZX 50 Index rose 116.38 points, or 1 percent, to 11,610.52. Within the index, 34 stocks rose and 16 fell. Turnover was $186.9 million. The experimental vaccine, developed by biotech company Moderna, safely induced an immune response against covid-19 in all 45 participants, researchers reported in The New England Journal of Medicine. Moderna has now announced that a phase 3...

More Markets

NZ sharemarket rocked by US inflation data
Markets Market close

NZ sharemarket rocked by US inflation data

The S&P/NZX 50 Index closed at 141.34 points or 1.18%.

Duncan Bridgeman 26 Apr 2024
Australian company seeks A$30m for Otago gold mining
Markets

Australian company seeks A$30m for Otago gold mining

Santana Minerals wants to 'rapidly advance' a South Island gold mining project.

John Anthony 26 Apr 2024
NZ sharemarket celebrates highest single-day rise in over five months
Markets Market close

NZ sharemarket celebrates highest single-day rise in over five months

The S&P/NZX 50 Index closed at 11,946.43, increasing 143.15 points or 1.21%.

Graham Skellern 24 Apr 2024
'Serious compliance breaches' in NZ sharemarket
Markets

'Serious compliance breaches' in NZ sharemarket

Seven matters were referred to the NZ Markets Disciplinary Tribunal last year.

Murray Jones 24 Apr 2024